Elicio Therapeutics, Inc.ELTXNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank67
3Y CAGR-57.7%
5Y CAGR-42.0%
Year-over-Year Change
Year-over-year free cash flow growth rate
3Y CAGR
-57.7%/yr
Annual compound
5Y CAGR
-42.0%/yr
Recent deceleration
Percentile
P67
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 0.50% |
| 2024 | -13.42% |
| 2023 | -43.48% |
| 2022 | 6.67% |
| 2021 | -6.70% |
| 2020 | 7.66% |
| 2019 | -209.61% |
| 2018 | 0.00% |
| 2013 | 84.26% |
| 2012 | 0.00% |